[ARWR] YoY Quarter Result on 31-Mar-2018 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
08-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q2]
Profit Trend
QoQ- -12.77%
YoY- -146.30%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 32,811 23,529 48,148 650 8,986 44 44 200.83%
PBT -26,818 -19,836 23,897 -14,884 -6,043 -20,816 -28,684 -1.11%
Tax -1,524 0 -0 -150 -81 -449 -413 24.28%
NP -26,818 -19,836 23,897 -14,884 -6,043 -20,816 -28,684 -1.11%
Tax Rate - - 0.00% - - - - -
Total Cost 59,629 43,364 24,251 15,534 15,028 20,860 28,728 12.93%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -81.73 -84.30 49.63 -2,289.45 -67.24 -47,579.11 -65,563.41 -67.16%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.26 -0.20 0.25 -0.18 -0.08 -0.35 -0.51 -10.61%
EPS Diluted -0.26 -0.20 0.24 -0.18 -0.08 -0.35 -0.51 -10.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.